2,3-Dihydroxybenzoic Acid

2,3-Dihydroxybenzoic Acid

SCHEMBL2831364

O=C([O-])c1cccc(O)c1O.O=C([O-])c1cccc(O)c1O.O=C([O-])c1cccc(O)c1O.[Fe+3]

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.61
HPGD P15428 4/20 0.61
KDM4E B2RXH2 4/20 0.61
TERT O14746 2/20 0.48
ALOX5 P09917 1/20 0.48
CA1 P00915 3/20 0.48
CA2 P00918 3/20 0.48
TDP1 Q9NUW8 2/20 0.48
CA6 P23280 2/20 0.48
HSD17B10 Q99714 2/20 0.48
ADAMTS4 O75173 1/20 0.48
EGFR P00533 1/20 0.48
LMNA P02545 1/20 0.48
FYN P06241 1/20 0.48
MMP2 P08253 1/20 0.48
MMP9 P14780 1/20 0.48
ALOX15 P16050 1/20 0.48
MMP8 P22894 1/20 0.48
CDK2 P24941 1/20 0.48
MMP12 P39900 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2,3-Dihydroxybenzoic Acid SCHEMBL30940445 0.95 ALDH1A1 (0.61) ALDH1A1HPGDKDM4ETERTALOX5
2,3-Dihydroxybenzoic Acid SCHEMBL31148351 0.95 ALDH1A1 (0.61) ALDH1A1HPGDKDM4ETERTALOX5
2,3-Dihydroxybenzoic Acid SCHEMBL10388912 0.95 ALDH1A1 (0.61) ALDH1A1HPGDKDM4ETERTALOX5
2,3-Dihydroxybenzoic Acid SCHEMBL28450784 0.95 ALDH1A1 (0.61) ALDH1A1HPGDKDM4ETERTALOX5
2,3-Dihydroxybenzoic Acid SCHEMBL2033960 0.95 KDM4E (0.68) ALDH1A1HPGDKDM4ETERTALOX5
2,3-Dihydroxybenzoic Acid SCHEMBL31178719 0.95 ALDH1A1 (0.61) ALDH1A1HPGDKDM4ETERTALOX5
2,3-Dihydroxybenzoic Acid SCHEMBL30315474 0.95 ALDH1A1 (0.61) ALDH1A1HPGDKDM4ETERTALOX5
2,3-Dihydroxybenzoic Acid SCHEMBL19953770 0.95 ALDH1A1 (0.61) ALDH1A1HPGDKDM4ETERTALOX5
2,3-Dihydroxybenzoic Acid SCHEMBL3980948 0.95 ALDH1A1 (0.61) ALDH1A1HPGDKDM4ETERTALOX5
2,3-Dihydroxybenzoic Acid SCHEMBL5677506 0.83 ALDH1A1 (0.48) ALDH1A1HPGDKDM4ETERTALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120142022-A1 GLYCOSYLATED MAMMALIAN NGAL AND USE THEREOF ABBOTT LABORATORIES (US) 2012-06-07 US disclosed
EP-2235053-A1 GLYCOSYLATED MAMMALIAN NGAL AND USE THEREOF Abbott Laboratories (US) 2010-10-06 EP disclosed
US-20090176274-A1 GLYCOSYLATED MAMMALIAN NGAL AND USE THEREOF ABBOTT LABORATORIES (US) 2009-07-09 US disclosed
US-20090123970-A1 GLYCOSYLATED MAMMALIAN NGAL AND USE THEREOF ABBOTT LABORATORIES (US) 2009-05-14 US disclosed
WO-2009052390-A1 GLYCOSYLATED MAMMALIAN NGAL AND USE THEREOF ABBOTT LABORATORIES (US) 2009-04-23 WO disclosed
EP-0721311-A4 SECOND SPHERE COMPLEXES AS RELAXATION AGENTS FOR IMAGE ENHANCEMENT IN MAGNETIC RESONANCE IMAGING UNIV TOLEDO (US) 1996-09-25 EP disclosed
EP-0721311-A1 SECOND SPHERE COMPLEXES AS RELAXATION AGENTS FOR IMAGE ENHANCEMENT IN MAGNETIC RESONANCE IMAGING THE UNIVERSITY OF TOLEDO (US) 1996-07-17 EP disclosed
US-5494656-A Second sphere complexes as relaxation agents for image enhancement in magnetic resonance imaging THE UNIVERSITY OF TOLEDO (US) 1996-02-27 US disclosed
WO-1995007653-A1 SECOND SPHERE COMPLEXES AS RELAXATION AGENTS FOR IMAGE ENHANCEMENT IN MAGNETIC RESONANCE IMAGING THE UNIVERSITY OF TOLEDO (US) 1995-03-23 WO disclosed